article thumbnail

Antitrust scrutiny of private equity deals intensifies

JD Supra: Mergers

Traditionally, private equity firms were seen as benign investors from an antitrust perspective. In the past 12 months, PE-funded acquisitions have faced progressively more rigorous scrutiny by antitrust authorities. This is changing. By: Allen & Overy LLP

article thumbnail

The Road Ahead for Private Equity: Reflections and Predictions

JD Supra: Mergers

The year 2023 will be remembered as a challenging one for private equity (PE), with complexities to navigate on many fronts. Although overall transaction volume was significantly down, private equity funds still found. By: Akin Gump Strauss Hauer & Feld LLP

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Optimizing the Value of a GP Advisory Board for Private Equity Funds

JD Supra: Mergers

Launching a private equity fund is an exciting yet daunting endeavor; and a General Partner (GP) Advisory Board can be a critical asset in navigating the complexities. By: Tonkon Torp LLP

article thumbnail

2024 Healthcare Private Equity Outlook & Trends

JD Supra: Mergers

As we begin 2024, we have highlighted the issues and trends that private equity (PE) investors should consider when evaluating transactions in the healthcare sector. Healthcare Continuation Funds: Strategic Considerations - With a sluggish 2023 for platform exits, an increasing number of PE funds looked to continuation funds to offer.

article thumbnail

California’s Bill Increasing Regulations on Private Equity Health Deals

JD Supra: Mergers

California is looking to take the lead on regulating private equity deals in the health care space by introducing bill AB 3129, which requires private equity groups or hedge funds to receive the state attorney general’s approval before purchasing a health care entity.

article thumbnail

California Assembly Bill 3129, Regulating Private Equity- and Hedge Fund-backed Healthcare Transactions, Awaiting Governor’s Approval

JD Supra: Mergers

AB 3129 would establish a mandatory approval process for a broad range of healthcare-related transactions involving private equity funds and hedge funds, giving the California Attorney General (“CA AG”) broad authority to block or impose restrictions on transactions to protect public interest. By: Goodwin

article thumbnail

California’s AB 3129 Continues National Trend of Scrutinizing Private Equity Investments in the Health Care Industry

JD Supra: Mergers

The California legislature is considering a bill that could severely impact the ability for private equity companies and hedge funds to operate in the California health care industry. By: Polsinelli